Loss of heterozygosity and DNA aneuploidy in colorectal adenocarcinoma

Annals of Surgical Oncology

Volumn 10, Issue 9, 2003, Pages 1086-1094

  Lin, Jen Kou ^a   Chang, Shih Ching ^a,b   Yang, Ya Chien ^c   Li, Anna Fen Yau ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Aneuploidy; APC; Colorectal neoplasms; Loss of heterozygosity; Microsatellite instability; p53

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER SURGERY; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PLOIDY; POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; ADENOCARCINOMA; COLORECTAL TUMOR; GENETICS; MIDDLE AGED;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 1542645761     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.12.014     Document Type: Article

References (43)

1. Gryfe R, Swallow C, Bapat B, et al. Molecular biology of colorectal cancer. Curr Probl Cancer 1997;21:233-300.
2. Verhest A, Kiss R, d'Olne D, et al. Characterization of human colorectal mucosa, polyps, and cancers by means of computerized morphonuclear image analyses. Cancer 1990;65:2047-54.
3. Jass JR, Mukawa K, Goh HS, Love SB, Capellaro D. Clinical importance of DNA content in rectal cancer measured by flow cytometry. J Clin Patliol 1989;42:254-9.
4. Offerhaus GJ, De Feyter EP, Cornelisse CJ, et al. The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology 1992;102:1612-9.
5. Richard JZ, Raouf EN, Ronald DB, James JK, Chan KM, Patricia M. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Cancer 1997;79:2073-86.
6. Purdie CA, Piris J. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Histopathology 2000;36:121-6.
7. Filatov L, Golubovskaya V, Hurt JC, Byrd LL, Phillips JM, Kaufmann WK. Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein. Oncogene 1998;16:1825-38.
8. Honma M, Momose M, Tanabe H, et al. Requirement of wild-type p53 protein for maintenance of chromosomal integrity. Mol Carcinog 2000;28:203-14.
9. Tarapore P, Fukasawa K. p53 mutation and mitotic infidelity. Cancer Invest 2000;18:148-55.
10. Rabinovitch PS, Dziadon S, Brentnall TA, et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999;59:5148-53.
11. Hruban RH, Wilentz RE, Kern SE. Genetic progression in the pancreatic ducts. Am J Pathol 2000;156:1821-5.
12. Eshleman JR, Casey G, Kochera ME, et al. Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53. Oncogene 1998;17: 719-25.
13. Sobin LH, Wittekind C. UICC TNM Classification of Malignant Tumors. 5th ed. New York: Wiley-Liss, 1997:66-9.
14. Dressier LG, Seamer L, Owens MA, Clark GM, McGuire WL. Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry. Cancer Res 1987;47:5294-302.
15. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR, Quirke P. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 1993; 67:1262-7.
16. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1999;58:5248-57.
17. Cianchi F, Balzi M, Becciolini A, et al. Correlation between DNA content and p53 deletion in colorectal cancer. Eur J Surg 1999; 165:363-8.
18. Pinto AE, Chaves P, Fidalgo P, Oliveira AG, Leitao CN, Soares J. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma. Dis Colon Rectum 1997;40:411-9.
19. Bauer KD, Bagwell CB, Giaretti W, et al. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 1993;14:486-91.
20. Salud A, Porcel JM, Raikundalia B, Camplejohn RS, Taub NA. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer. J Surg Oncol Suppl 1999;72:167-74.
21. Dean PA, Vernava AM III. Flow cytometric analysis of DNA content in colorectal carcinoma. Dis Colon Rectum 1986;29:184-6.
22. Lanza G, Gafa R, Santini A, et al. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer 1998;82:49-59.
23. Thiagalingam S, Laken S, Willson JK, et al. Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci U S A 2001;98:2698-702.
24. Fodde R, Kuipers J, Rosenberg C, et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 2001;3:433-8.
25. Kaplan KB, Burds AA, Swedlow JR, Bekir SS, Sorger PK, Nathke IS. A role for the adenomatous polyposis coli protein in chromosome segregation. Nat Cell Biol 2001;3:429-32.
26. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wildtype p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992;70:937-48.
27. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992;70:923-35.
28. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-8.
29. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51(23 Pt 1):6304-11.
30. Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebermann DA. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 1995; 10:2263-70.
31. Urbani L, Stearns T. The centrosome. Curr Biol 1999;9:R315-7.
32. Lange BM, Faragher AJ, March P, Gull K. Centriole duplication and maturation in animal cells. Curr Top Dev Biol 2000;49:235-49.
33. Weber RG, Bridger JM, Benner A, et al. Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations. Cytogenet Cell Genet 1998;83:266-9.
34. Carroll PE, Okuda M, Horn HF, et al. Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 1999;18:1935-44.
35. Tarapore P, Horn HF, Tokuyama Y, Fukasawa K. Direct regulation of the centrosome duplication cycle by the p53-p21 Waf1/Cip1 pathway. Oncogene 2001;20:3173-84.
36. Hollander MC, Sheikh MS, Bulavin DV, et al. Genomic instability in Gadd45a-defecient mice. Nat Genet 1999;23:176-84.
37. Reid T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996;15:234-45.
38. De Angelis PM, Clausen OP, Schjolberg A, Stokke T. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer 1999;80:526-35.
39. Fujiwara Y, Ohata H, Emi M, et al. A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer. Genes Chromosomes Cancer 1994;10:7-14.
40. Yaremko ML, Recant WM, Westbrook CA. Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers. Genes Chromosomes Cancer 1995;13:186-91.
41. Fujiwara Y, Emi M, Ohata H, et al. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 1993;53:1172-4.
42. Yaremko ML, Wasylyshyn ML, Paulus KL, Michelassi F, Westbrook CA. Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinomas. Genes Chromosomes Cancer 1994;10:1-6.
43. Miyazaki M, Furuya T, Shiraki A, Sato T, Oga A, Sasaki K. The relationship of DNA ploidy to chromosomal instability in primary human colorectal cancers. Cancer Res 1999;59:5283-5.